1671-5144
2003 Issue 3
..............page:Ⅰ-Ⅱ
..............page:154
NCCN breast cancer practice guidelines
liao ning ; wang kun ; wu yi long
liao ning ; wang kun ; wu yi long
..............page:167-192
Analysis of articles on therapy published in 3 oncology journals during 2000-2003
gan ke jian ; pei xiao qing ; hong ming huang
gan ke jian ; pei xiao qing ; hong ming huang
..............page:142-144,148
Comment
zhang guo zuo ; qu wan ying ; tang an wu
zhang guo zuo ; qu wan ying ; tang an wu
..............page:140-141
A comparative study of 18FDG-PET and CT on diagnosing mediastinal lymph nodes in non-small cell lung cancer -- an SROC-based meta-analysis for literature published between 1999 and 2002
yang zuo ji ; wu yi long ; yan jie
yang zuo ji ; wu yi long ; yan jie
..............page:132-140
..............page:129-131
Letrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women
wang kun ; yang xue ning
wang kun ; yang xue ning
..............page:163-166
Adjuvant oophorectomy and tamoxifen treatment in patients with estrogen receptor-positive and HER2/neu over expressive breast cancer
wang kun ; yang xue ning
wang kun ; yang xue ning
..............page:160-162
Anastrozole: a choice of adjuvant endocrine therapy for postmenopausal women with early breast cancer
wang kun ; yang xue ning
wang kun ; yang xue ning
..............page:155-159
The role of goserelin as adjuvant therapy in premenopausal patients with node-positive breast cancer
huang yi sheng ; wu yi long
huang yi sheng ; wu yi long
..............page:152-154
Adjuvant tamoxifen treatment in DCIS
liao ning ; wu yi long
liao ning ; wu yi long
..............page:149-151
Chemoprevention of tamoxifen on benign breast disease in women
wang kun ; yang xue ning
wang kun ; yang xue ning
..............page:145-148